Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
Clinical trial NCT05171335 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT05171335
- Sponsor
- The Methodist Hospital Research Institute
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-20
- Primary completion
- 2026-06-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.